Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ertl

Showing results (181-190 of 2,883) with videos related to

Pageof 289
Sort By:
Journal of Immunogenetics|April 1, 1977
Cytotoxic interactions of virus specific effector cells with virus infected targets of different cell typeU Koszinowski, H Ertl
European Heart Journal|April 1, 1990
New aspects of drug therapy in ischaemic heart disease. IntroductionG Ertl, K Kochsiek
European Heart Journal|August 1, 2013
CardioPulse: the strengths and limitations of the German health-care systemGeorg Ertl, Till Neumann
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|April 18, 2008
Cheminformatics analysis of natural products: lessons from nature inspiring the design of new drugsPeter Ertl, Ansgar Schuffenhauer
IEEE Transactions on Visualization and Computer Graphics|November 23, 2016
Progressive Direct Volume-to-Volume TransformationSteffen Frey, Thomas Ertl
Medizinische Klinik (Munich, Germany : 1983)|March 18, 2008
[The problem of rare diseases: a challenge for teaching, research and patient care]Georg Ertl, Alfred Hildebrandt
Wiener Medizinische Wochenschrift (1946)|May 15, 1980
[Results of surgical treatment in 558 patients with carcinoma of the rectum (author's transl)]W Köle, M Ertl
Radiobiologia, Radiotherapia|January 1, 1980
[The dependence of the optimal discriminator adjustment of a single-channel analyzer on the scattered radiation and on the energy resolution of the detector]S Ertl, M Tautz
Basic Research in Cardiology|September 1, 1980
A model for the investigation of regional coronary vascular resistances. Physical features as compared with experimental resultsF Simm, G Ertl
Circulation|September 29, 2012
Adverse cardiac remodeling: phosphoinositide 3-kinase, another unique factor in a multifactorial conditionGeorg Ertl, Stefan Frantz
Pageof 289

Showing results (181-190 of 2,883) with videos related to

Sort By:
Pageof 289
Journal of Immunogenetics|April 1, 1977
Cytotoxic interactions of virus specific effector cells with virus infected targets of different cell typeU Koszinowski, H Ertl
European Heart Journal|April 1, 1990
New aspects of drug therapy in ischaemic heart disease. IntroductionG Ertl, K Kochsiek
European Heart Journal|August 1, 2013
CardioPulse: the strengths and limitations of the German health-care systemGeorg Ertl, Till Neumann
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|April 18, 2008
Cheminformatics analysis of natural products: lessons from nature inspiring the design of new drugsPeter Ertl, Ansgar Schuffenhauer
IEEE Transactions on Visualization and Computer Graphics|November 23, 2016
Progressive Direct Volume-to-Volume TransformationSteffen Frey, Thomas Ertl
Medizinische Klinik (Munich, Germany : 1983)|March 18, 2008
[The problem of rare diseases: a challenge for teaching, research and patient care]Georg Ertl, Alfred Hildebrandt
Wiener Medizinische Wochenschrift (1946)|May 15, 1980
[Results of surgical treatment in 558 patients with carcinoma of the rectum (author's transl)]W Köle, M Ertl
Radiobiologia, Radiotherapia|January 1, 1980
[The dependence of the optimal discriminator adjustment of a single-channel analyzer on the scattered radiation and on the energy resolution of the detector]S Ertl, M Tautz
Basic Research in Cardiology|September 1, 1980
A model for the investigation of regional coronary vascular resistances. Physical features as compared with experimental resultsF Simm, G Ertl
Circulation|September 29, 2012
Adverse cardiac remodeling: phosphoinositide 3-kinase, another unique factor in a multifactorial conditionGeorg Ertl, Stefan Frantz
Pageof 289